On Dec. 2, 2020, Codex DNA announced the release of seven new synthetic SARS-CoV-2 genomes for use in the development of vaccines, therapeutics, and diagnostics to help in the COVID-19 pandemic response.<.p>The BioXpﾙ 3250 system is a fully automated synthetic biology platform that successfully created the first full-length SARS-CoV-2 synthetic genome de novo in April of this year.